Abstract:Abstract: Cancer, a diverse group of diseases characterized by abnormal cell growth and the potential to spread throughout the body, accounts for approximately 10 million deaths globally each year. Current cancer therapies, including chemotherapy, radiation, and various pharmacological treatments, present several challenges and potential side effects. It is important to differentiate these conventional methods, which often involve synthetic drugs, from adjuvant therapies that might be used in conjunction. As a result, there is an increasing interest in alternative therapies, particularly in agents derived from natural sources for cancer treatment. Secondary metabolites have shown promise in promoting the development of new clinical drugs with various anti-cancer mechanisms. This review focuses on the anti-cancer potential of the novel metabolite Andrographolide, extracted mainly from Andrographis paniculata. The chemopreventive properties and the ability to inhibit various signaling pathways across different types of cancers without side effects posit Andrographolide as a promising natural antitumour agent. The review identified that Andrographolide inhibits multiple signaling pathways, contributing to its anti-proliferative, anti-metastatic, and apoptotic effects in various cancers. The compound's natural origin and lack of adverse side effects make it particularly attractive as a therapeutic agent. However, further detailed studies are needed to fully understand its specific mechanisms and potential clinical applications. Andrographolide presents a compelling option as a natural anticancer agent with the potential to overcome some limitations of traditional cancer treatments. Its broad spectrum of anti-cancer activities and absence of side effects highlight its therapeutic potential. The review highlights that continued research and clinical studies are important for confirming the effectiveness and safety of Andrographolide in human use, alongside optimizing dosage and delivery techniques.

Effects of distamycin A & netropsin on condensation of mitotic chromosomes in early embryos & larval brain cells of Drosophila nasuta.

Advances in Ameliorating Inflammatory Diseases and Cancers by Andrographolide: Pharmacokinetics, Pharmacodynamics, and Perspective

Andrographolide and its derivatives: Current achievements and future perspectives

Current Evidence on Molecular Mechanisms of Andrographolide in Cancer

Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer

Targeting signaling pathways with andrographolide in cancer therapy (Review)

High-sensitivity FM spectroscopy with a lead-salt diode laser.

Current Trends on Repurposing and Pharmacological Enhancement of Andrographolide

Biological properties of andrographolide, an active ingredient of Andrographis Paniculata: a narrative review

Right bundle branch block updated.

Clinical Efficacy and Potential Mechanisms of Acupoint Stimulation Combined With Chemotherapy in Combating Cancer: A Review and Prospects

Resveratrol: an Overview of Its Anti-Cancer Mechanisms

Recent progress on triterpenoid derivatives and their anticancer potential

Advances In Combination Of Antiangiogenic Agents Targeting Vegf-Binding And Conventional Chemotherapy And Radiation For Cancer Treatment

Research Progress on the Synergistic Anti-Tumor Effect of Natural Anti-Tumor Components of Chinese Herbal Medicine Combined with Chemotherapy Drugs

Cellular and molecular mechanisms of oroxylin A in cancer therapy: Recent advances

Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cells.

Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response

Tumour protein 53 is linked with type 2 diabetes mellitus

Withanolides: Promising candidates for cancer therapy

Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?